Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109215) titled 'A Study Using Artificial Intelligence to Predict Treatment Success and Survival in Patients with Rectal, Pancreatic, and Liver Cancers' on April 23.
Study Type: Observational
Study Design:
Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: Dr. Reena Engineer
Condition:
Health Condition 1: C229- Malignant neoplasm of liver, not specified as primary or secondary
Health Condition 2: C259- Malignant neoplasm of pancreas, unspecified
Health Condition 3: C20- Malignant neoplasm of rectum
Interve...